Viewing Study NCT06146257


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2025-12-25 @ 4:38 PM
Study NCT ID: NCT06146257
Status: RECRUITING
Last Update Posted: 2025-10-21
First Post: 2023-11-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Sponsor: GluBio Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module